Table:
begin	end	state
1	11	cytoplasmic
12	33	transmembrane
34	40	non-cytoplasmic
41	65	transmembrane
66	95	cytoplasmic
96	118	transmembrane
119	153	non-cytoplasmic
154	173	transmembrane
174	183	cytoplasmic
184	204	transmembrane
205	224	non-cytoplasmic
225	247	transmembrane
248	258	cytoplasmic
259	284	transmembrane
285	301	non-cytoplasmic
302	327	transmembrane
328	347	cytoplasmic
348	371	transmembrane
372	385	non-cytoplasmic
386	401	transmembrane
402	407	cytoplasmic
408	426	transmembrane
427	439	non-cytoplasmic
440	465	transmembrane
466	467	cytoplasmic

Input:
>AO356_07535
MSTDKVSVHGSWASRWVFILAATGSAVGLGSIWKFPYMVGVYGGGAFVLMFLACIALIGA
PVMLAETLIGRRARQSPANALKVLAVEAGHSTKWSWGAFAGMITALLILSFYSVVGGWSL
DYIIDMGRGDFQGATPDQVGAYFGNVIADPWRLTLWHTIFMVLSAVVIARGVVAGLERSL
RIMMPLLFVMILVLLGYSMTTGHFMEGVHFMFDFQPEKVLDGLLPAMGHAFFSLSVGVGS
IMIYGAYMPKNASLTRTVFGVALLDTFVSLLAGVALFPIVFAAGLNPSEGPGLMFVSLPF
AFGSMAFGQVMGVVFFVLVAIAAWSSAISLLEPMVAYLVERTRISRAWVTFWLAFTCWFV
GLGTVFSFNIWKQAKFFVNEGGLFHLYQWGATGGLDFFGVIDFFTSRIMLPLGGLCFVVF
AGWVMGRDAVRDELSLRSPVLFALSLFLMRYVAPIGILVVFAAQLWK

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server